Pinatuzumab vedotin is an antibody-drug conjugate (ADC) that is a humanized monoclonal antibody against CD22, Pinatuzumab, conjugated to VcMMAE. Pinatuzumab vedotin has anti-tumor activity.

Physicochemical Properties

CAS #	1313706-14-7
Synonyms	anti-CD22-vc-MMAE; DCDT2980S
Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

References

[1]. Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Clinical Trial Clin Cancer Res. 2017 Mar 1;23(5):1167-1176.

Solubility Data